Target Name: LOC101927627
NCBI ID: G101927627
Review Report on LOC101927627 Target / Biomarker Content of Review Report on LOC101927627 Target / Biomarker
LOC101927627
Other Name(s): LOC101927627 variant X1 | Uncharacterized LOC101927627, transcript variant X1 | uncharacterized LOC101927627

LOC101927627: A Potential Drug Target and Biomarker

LOC101927627 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. Its unique structure and expression pattern have led to its potential as a drug target or biomarker.

The protein encoded by LOC101927627 is composed of 1,943 amino acids and has a calculated molecular weight of 29.9 kDa. It is characterized by a N-terminus, a catalytic C-terminus, and a C-terminal hypervariable region (HVR). The HVR is responsible for the unique structure and function of the protein.

LOC101927627 has been shown to play a role in several physiological processes, including cell signaling, metabolism, and inflammation. For example, studies have shown that LOC101927627 is involved in the regulation of cell adhesion, cell signaling, and the production of reactive oxygen species (ROS).

In addition to its role in cellular processes, LOC101927627 has also been shown to be involved in the regulation of inflammation. Studies have shown that LOC101927627 can modulate the production of pro-inflammatory cytokines and chemokines, and can also inhibit the production of anti-inflammatory cytokines.

Given its unique structure and function, LOC101927627 has potential as a drug target or biomarker. Studies have shown that LOC101927627 can be targeted by small molecules, including inhibitors of tyrosine kinase, inhibitors of protein tyrosination, and inhibitors of NF-kappa-B signaling. Additionally, LOC101927627 has been shown to interact with several protein partners, including PDGF, NF-kappa-B, and NF-kappa1.

In addition to its potential as a drug target or biomarker, LOC101927627 has also been shown to be a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that LOC101927627 is overexpressed in several types of cancer, including breast, ovarian, and colorectal cancer. Additionally, LOC101927627 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Overall, LOC101927627 is a protein that has the potential to be a drug target or biomarker. Its unique structure and function, as well as its involvement in several physiological processes and its potential as a biomarker for several diseases, make it an attractive target for further study. Further research is needed to fully understand the role of LOC101927627 in cellular and biological processes, as well as its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC101927627

The "LOC101927627 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC101927627 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC101927636 | LOC101927668 | LOC101927712 | LOC101927727 | LOC101927741 | LOC101927745 | LOC101927770 | LOC101927787 | LOC101927825 | LOC101927827 | LOC101927834 | LOC101927840 | LOC101927853 | LOC101927855 | LOC101927857 | LOC101927863 | LOC101927896 | LOC101927897 | LOC101927910 | LOC101927932 | LOC101927942 | LOC101927947 | LOC101927960 | LOC101927967 | LOC101927971 | LOC101927995 | LOC101927998 | LOC101928004 | LOC101928007 | LOC101928008 | LOC101928012 | LOC101928014 | LOC101928047 | LOC101928053 | LOC101928080 | LOC101928093 | LOC101928120 | LOC101928135 | LOC101928143 | LOC101928152 | LOC101928163 | LOC101928180 | LOC101928195 | LOC101928201 | LOC101928219 | LOC101928230 | LOC101928251 | LOC101928268 | LOC101928269 | LOC101928272 | LOC101928273 | LOC101928274 | LOC101928281 | LOC101928331 | LOC101928334 | LOC101928338 | LOC101928344 | LOC101928347 | LOC101928351 | LOC101928354 | LOC101928371 | LOC101928372 | LOC101928373 | LOC101928381 | LOC101928385 | LOC101928387 | LOC101928391 | LOC101928416 | LOC101928417 | LOC101928423 | LOC101928437 | LOC101928438 | LOC101928446 | LOC101928462 | LOC101928463 | LOC101928495 | LOC101928499 | LOC101928505 | LOC101928510 | LOC101928512 | LOC101928516 | LOC101928524 | LOC101928540 | LOC101928565 | LOC101928570 | LOC101928592 | LOC101928618 | LOC101928621 | LOC101928622 | LOC101928635 | LOC101928663 | LOC101928697 | LOC101928699 | LOC101928704 | LOC101928718 | LOC101928743 | LOC101928760 | LOC101928762 | LOC101928796 | LOC101928804